Play Back Videos

Play Back Videos



* The programme is in Hong Kong Time (HKT: GMT+8)
Saturday, 12th December 2020
09:30 - 09:40 Opening JYW Lau, AYB Teoh, TWC Mak
Session 1 Hepatobiliary and Pancreatic Surgery Chair: KF Lee, FPT Mok
09:40 - 10:00 Minimal Invasive Approach to Pancreatic Head Cancer Horacio J Asbun
10:00 - 10:20 Recent Progress in Pancreatic Cancer Richard D Schulick
10:20 - 10:40 Application of Liver Transplant Techniques in Complex Hepatobiliary Surgery Kelvin KC Ng
10:40 - 10:45 Discussion
Session 2 Upper Gastrointestinal and Metabolic Surgery Chair: EKW Ng, AYB Teoh
10:45 - 11:05 Latest Advances in Endoscopic and Laparoscopic Management of Gastroesophageal Reflux Disease (GERD) Aurora D Pryor
11:05 - 11:25 Bypass or Sleeve Gastrectomy for Bariatric Patients with GERD? Alfons Pomp
11:25 - 11:45 Endoscopic Versus Surgical Management of Oesophageal Motility Disorders Vivien WY Wong
11:45 - 11:50 Discussion
Session 3 Endocrine Surgery Chair: SYW Liu, DMY Kan
11:50 - 11:10 Current Updates on the Management of Adrenocortical Carcinoma Barbra S Miller
12:10 - 12:30 Neuro-monitoring during Thyroidectomy - Application and Consideration from Surgeons' Perspective Ben KP Wong
12:30 - 12:50 Tips and Tricks of Transoral Endoscopic Thyroidectomy Weida Day
12:50 - 12:55 Discussion
Sponsored Symposium
Olympus Symposium Chair: KKC Ng, AYB Teoh
13:00 - 13:30 Technical Tips for Laparoscopic Anatomic Liver Resection Kazuteru Monden
Medtronic Symposium Chair: SSM Ng, AYB Teoh
13:30 - 14:00 Laparoscopic TME with Lateral Lymph Node Dissection Using a Novel LigaSure Technique Takashi Nonaka
Session 4 Lower Gastrointestinal Surgery Chair: SSM Ng, TWC Mak
14:00 - 14:20 Minimally Invasive Abdominoperineal Excision (APE)/ Extralevator Abdominoperineal Excision (ELAPE) Peter CC Chen
14:20 - 14:40 Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) – Why and How I Do It? Craig Lynch
14:40 - 15:00 Low Anterior Resection Syndrome - How Long Does It Last? Kaori Futaba
15:00 - 15:05 Discussion
Session 5 Sarcoma Surgery Chair: K Futaba, TWC Mak
15:05 - 15:25 Surgery for Retroperitoneal Sarcoma in the Modern Era Marco Fiore
15:25 - 15:45 Surgery of the Spine and Sacrum - a Multidisciplinary Approach Anant Desai
15:45 - 16:05 Neoadjuvant and Adjuvant Therapies for Retroperitoneal Sarcomas Herbert HF Loong
16:05 - 16:10 Discussion
Session 6 Robotics and Surgical Innovation Chair: PWY Chiu, Z Li
16:10 - 16:30 New Paradigms in Surgical Robotics Lee L Swanstrom
16:30 - 16:50 Robotic Gastrectomy - Advances and Innovation Woo-Jin Hyung
16:50 - 17:10 Innovation in Robotic Surgery - an Engineering Perspective Samuel KW Au
17:10 - 17:15 Discussion
17:15 - 17:20 Closing remarks JYW Lau, AYB Teoh & TWC Mak


Registration Fee
Free of charge


Saturday, 12th December 2020

CME/CNE Accreditation
Accreditation is given by the following Colleges on the condition that the College fellows attend the webinar on 12 Dec by signing into their accounts AND completing the requested e-form. The login and logout time will serve as a proof of attendance to support the application for CME/CNE points. Data will be extracted by the secretariat after the symposium and submitted to relevant Colleges for their vetting and approval.

College CME / CNE Points
The Hong Kong College of Family Physicians Pending
The Hong Kong College of Otorhinolaryngologists Pending
Hong Kong College of Physicians 3.5
Hong Kong College of Radiologists 7.5
The College of Surgeons of Hong Kong Pending
Continuing Nursing Education (CNE) 7

Official Language
English is the official language of the Symposium. There will be no simultaneous translation.

** The Organizer reserves the right to amend the program and information here.





Department of Surgery, The Chinese University of Hong Kong


Department of Surgery, The Chinese University of Hong Kong
4/F Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, Shatin, Hong Kong
Tel: (852) 3505 2952
Fax: (852) 2635 3487
Email: cuhkss@surgery.cuhk.edu.hk
Website: http://www.surgery.cuhk.edu.hk/cuhkss2020

On-line Registration | CUHKSS 2020

Horacio Asbun, M.D., FACS SAGES President
Chief of Hepatobiliary and Pancreatic Surgery
Miami Cancer Institute, USA

Horacio Asbun, M.D., FACS, is Chief of Hepatobiliary and Pancreatic Surgery at Miami Cancer Institute and Professor of Surgery at Mayo Clinic College of Medicine and Science. Prior to this role, he served as Chairman of General Surgery at Mayo Clinic in Jacksonville, Fla.. (2008-2018)

Dr. Asbun is President-Elect (2020-2021) of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and Executive Member of the Board of Governors. He also served as a member of the Executive Council of the American Hepato-Pancreatic Biliary Association (AHPBA), Chairman of the Video-Based Education of the American College of Surgeons and is a founding Board Member of The G4 Alliance, the International Laparoscopic Liver Society and the International Minimally Invasive Pancreas Surgery consortium.

Dr Asbun is the Editor-in-Chief of the American College of Surgeons Multimedia Atlas of Surgery and is on the Editorial Board of Surgical Endoscopy. He has served as a panel member on the National Comprehensive Cancer Network (NCCN) guidelines for pancreatic cancer and a member of 25 Medical Societies. He has been, and currently is a member, Chair or Co-Chair of multiple Committees on several major US surgical societies.

Dr Asbun is a member of multiple international expert’s surgical initiatives and expert study groups. Among them, International Study Group of Pancreas Surgery (ISGPS), Tokyo Guidelines (TG 18), European Guidelines on Laparoscopic Liver Surgery (EGMLLS), International Consensus on Laparoscopic Liver Resection (ICLLR), International Consensus on Prevention of Bile Duct Injury. He currently serves as the Chair of the Evidence-Based, International Guidelines in Minimally Invasive Pancreas Resection (IG-MIPR).

Dr Asbun has published more than 150 peered-reviewed scientific articles and 110 peer-reviewed surgical videos. He is author of over 35 book chapters and editor of 6 Surgical Books. He serves as a reviewer for numerous scientific journals. He directs and teaches national and international courses on surgery and speaks frequently at scientific conferences around the world, with, to-date, more than 240 presentations in the US and over 410 invited presentations in Europe, Asia, Africa, Oceania, Central and South America. He is an Honorary Fellow of several International Surgical Societies and has received multiple awards.

His publications are in the areas of liver, pancreas, biliary and endocrine surgery, minimal invasive surgery, surgical oncology, as well as basic science research in the field of surgical oncology.

Peter, Chien-Chih Chen, MD
Attending Physician, Section of Colon and Rectal Surgery
Sun Yat-Sen Cancer Center, Taipei

Dr. Chen was born in Yangmei District, Taoyuan City, Taiwan in 1972 and graduated from National Yang-Ming University School of Medicine in 1999. He then completed his surgical residency training at Taipei Veterans General Hospital and Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC) before further completing subspecialty training in Colorectal Surgery. Since completion of subspecialty training in 7/2014, Dr. Chen has been an Attending Colorectal Surgeon at KFSYSCC. He is currently both senior staff member in the Department of Surgery and chairperson of the multidisciplinary colorectal cancer committee.

Dr. Chen's first stride in the field of Colorectal Surgery was his increased utilization of abdominal laparoscopy, alongside development of an enhanced postoperative recovery program, in 2007. In 2009, he completed an advanced laparoscopy observership under the tutelage of Dr. Jeffrey Milsom at Weill-Cornell Presbyterian Hospital in New York City. In 2010, Dr. Chen began implementing single-incision abdominal laparoscopic Colorectal Surgery (SILS) into his practice, and said method has since then become a standard of care at KFSYSCC.

After more than six months of preparation and advanced education, Dr. Chen successfully completed his personal first case of transanal total mesorectal excision (taTME) in May of 2013. Since that time, he has intensely dedicated his practice to the advancement of this field. His experiences led to the publication of the first case series regarding taTME originating from Asia in Surgical Endoscopy in 2015. This was then followed by the publication of a case-matched analysis comparing traditional laparoscopic TME to taTME for rectal cancer patients who had undergone neoadjuvant chemoradiation therapy in Annals of Surgical Oncology. In 2016, Dr. Chen coordinated the first taTME workshop in Taiwan, followed in 2017 by two cadaver hand-on sessions. He also presented a 120-patient taTME case mid-term survival summary at the 2017 European Association of Endosopic Surgery Annual Meeting (EAES). Beginning in 2018, Dr. Chen was invited to present and as a trainer in standardized taTME training sessions in Beijing, Singapore, and other various Asian cities. Furthermore, he also led KFSYSCC as the first Asian center in recruitment into COLOR III, a multinational randomized clinical trial comparing taTME to traditional laparoscopic TME.

More recently, Dr. Chen has also delved into robotics-assisted surgery for Colorectal Cancer, fusing robotics-arm utilization with a transanal approach. Publications regarding these experiences are forthcoming in various international journals.

Since 2005, Dr. Chen has also been a Taiwan Ministry of Education approved lecturer, lecturing in the field of Surgery at National Yang Ming University School of Medicine. He also took on an analytics role at the Taiwan National Cancer Registry in 2008 and has since then generated annual reports. In 2011, he was appointed to the Taiwan National Health Research Institutes Colorectal Cancer Committee and has played key roles in guiding research that has ultimately determined colorectal cancer treatment quality indicators for the nation. He also represents the committee to have the presentation about the national cancer registration data in many local and international conferences. Dr. Chen also received appointment as an instructor of Surgical Oncology to the Taiwan Oncology society in 2012, followed by elected as a board member at the Taiwan Society of Colon and Rectal Surgeons in 2018. Most recently, he was appointed member of editorial board for the Asian Journal of Surgery in 2019.

Anant Desai
Consultant Surgeon, Queen Elizabeth Hospital
University Hospitals Birmingham, UK

Mr Anant Desai completed undergraduate education at Queens’ College Cambridge and the Royal Free Hospital, London. Following this he gained an MD investigating angiogenesis in oesophageal cancer at the University of Birmingham before completing Fellowships in Paris and Milan. He was appointed as Consultant Surgeon to the Midlands Abdominal and Retroperitoneal Sarcoma Unit in 2011.

Mr Desai undertakes all aspects of abdominal sarcoma surgery as well as complex surgical oncology and surgery for advanced pelvic malignancy.

Research interests include whole genomic sequencing in sarcoma and pre-operative psychological intervention in patients undergoing major surgery. Publications range from International Consensus statements for the treatment of sarcoma to multi-centre studies of rare tumours.

Mr Desai is a member of the Sarcoma UK research advisory committee, is an editor of the European Journal of Surgical Oncology, is co-chair of the West Midlands Sarcoma Advisory Group and leads the regional soft tissue sarcoma multi-disciplinary team.

Marco Fiore, MD
Attending Surgeon, Sarcoma Service
IRCCS Foundation National Cancer Institute, Italy

Marco Fiore (Milan, 1975) is in charge as Attending Surgeon at Sarcoma Service of Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan – Italy, and appointed for Retroperitoneal Sarcoma Surgery. He has been full time committed for Soft Tissue Sarcoma, GIST and Rare Tumors surgery since 2002. He serves as member of the International Committee of SSO, and member of the Education and Training Committee of ESSO. He is also Chair of Sarcoma Oncoteam of SICO (Italian Society of Surgical Oncology), and Director of ESSO European School of Soft Tissue Sarcoma Surgery. He yearly coordinates the CME accreditated educational event ReSurge, Retroperitoneal Surgery Course at INT. He is active and founding member of the Transatlantic Retroperitoneal Sarcoma Working Group, and is in charge as coordinator of the group website (www.tarpswg.org). He is also member of Connective Tissue Oncology Society (CTOS), Italian Sarcoma Group (ISG), European Society of Medical Oncology (ESMO). He participates to the EORTC Soft Tissue and Bone Sarcoma Group activities.

Dr. Fiore collaborates as member of Editorial Advisory Board of European Journal of Surgical Oncology (EJSO) and previously served within Editorial Board of Annals of Surgical Oncology (2015-2018). He authored or co-authored more than 90 manuscripts in peer-reviewed international journals.

Woo-Jin Hyung, MD, PhD
Professor and Chief of Gastrointestinal Surgery, Department of Surgery
Yonsei University College of Medicine, Seoul

Professor Woo Jin Hyung is currently the Director of the Gastric Cancer Center at Yonsei Cancer Hospital, Yonsei University Health System. He is also a Professor in the Department of Surgery at Yonsei University College of Medicine.

Professor Hyung obtained his MD degree from Yonsei University in 1993. He subsequently started his internship/ residency at Severance Hospital. Following military service as a public health doctor in 2001, he entered a fellowship at the Department of Surgery of, Severance Hospital, Yonsei University College of Medicine, where he continued forward to become a Professor in 2013. In 2011, he became Director of the Severance Hospital Robot & MIS Center before becoming Chief of Gastrointestinal Surgery at Yonsei in 2013. Since 2013, he has taken on his role as Director of the Gastric Cancer Center.

Professor Hyung is a specialist in in minimally invasive gastric cancer surgery. His areas of research interest are gastric oncology surgery and particularly in image-guided surgery in gastric cancer patients.

Craig Lynch
Associate Professor
University of Melbourne, Australia

Craig is an Associate Professor at the University of Melbourne, completing his General Surgical Fellowship in New Zealand, with post-fellowship training in Colorectal Surgery at the Cleveland Clinic, Cleveland, Ohio, and St Vincent's Hospital in Melbourne. He currently practices at the Sydney Adventist Hospital in Sydney and the Epworth Hospital in Melbourne.

He holds a Masters degree in surgery and has published over 80 peer-reviewed manuscripts. He is a Fellow of the Colorectal Surgical Society of Australia and New Zealand and International Fellow of the American Society of Colon & Rectal Surgeons.

He has extensive minimally invasive surgical experience with both laparoscopic and robotic surgery, being the first to perform robotic colorectal surgery in Australasia in 2009. His current clinical practice also includes advanced pelvic cancer, and peritoneal carcinomatosis performing cytoreduction and HIPEC, and minimally invasive PIPAC for advanced peritoneal malignancy.

Barbra S. Miller, MD
Associate Professor, Division of Endocrine Surgery, Department of Surgery
The Ohio State University Wexner Medical Center, USA

Barbra S. Miller is an Associate Professor in the Division of Endocrine Surgery, Section of General Surgery.

Dr. Miller received her medical degree from the University of Cincinnati College Of Medicine and went on to complete both an internship and a residency in general surgery at University of Texas Southwestern in Dallas, Texas.

Dr. Miller did her Fellowship in Endocrine Surgery at University of Michigan. She then served as Assistant Professor in the Endocrine Surgery Division at the University of Texas Health Science Center in San Antonio before re-joining the University of Michigan Department of Surgery in 2007. Her entire practice is focused on endocrine surgery. She is a member of the multidisciplinary endocrine oncology team. Her practice and research focuses on adrenal disorders and adrenal cancer.

Alfons Pomp
Professor of Surgery
University of Montreal Hospital Center, Canada

Dr. Pomp is an internationally recognized expert in performing and teaching advanced laparoscopic surgical techniques. He is a graduate of McGill University and the Université de Sherbooke. He completed his surgical training at the University of Montreal and Brown University in Rhode Island and practiced in Montreal (Hotel Dieu) for a decade before relocating to New York city – the Mount Sinai Hospital and then the Weill Cornell/New York Presbyterian where he became the Chief of GI, Metabolic and Bariatric Surgery, the endowed Leon C. Hirsch Professor of Surgery and the Vice-Chairman of the Department of Surgery. He recently returned to Montreal where he is a Professor of Surgery and assistant to the Director of Professional Services working to evaluate new technologies for the Centre Hospitalier de l'Université de Montreal (CHUM).

Dr. Pomp has written more than 160 PubMed cited articles, 30 book chapters and has been a speaker at over 250 national and international meetings. He was funded as a Principal Investigator in NIDDK/NIH Bariatric Surgery Research - LABS (Longitudinal Assessment of Bariatric Surgery). He is member of several surgical societies, including the American Surgical Association. He has served on the executive boards of SAGES and ASMBS and served on the Editorial board of SOARD and Obesity Surgery.

He has been frequently named as one of Castle Connolly's America's Top Doctors; won the SAGES Clinical Excellence Award (now the Arnold P. Gold Foundation Excellence in Humanistic Clinical Care Award) in 2013 and was honored as an ASMBS "Thirty Members Who Made a Difference 1983-2013"

Aurora D. Pryor SAGES Immediate Past President
Professor of Surgery & Chief of Bariatric, Foregut and Advanced GI Surgery
Stony Brook University, USA

Dr. Aurora is Professor and Vice Chair of Surgery at Stony Brook. She grew up in Ann Arbor, Michigan and received her undergrad degree in engineering and her MD from Duke University. She completed her residency in General Surgery at Duke, followed by a fellowship in minimally invasive surgery. She was on the faculty at Duke from 2003-2011. While at Duke, she served as Co-Director of the Metabolic and Weight Loss Surgery Program at Duke and as Chief of General Surgery at Durham Regional Hospital. She was associate director of the Duke residency and the Duke MIS/bariatric fellowship program director. Moving to New York in 2011, she now serves as Vice Chair of Surgery, Chief of Bariatric, Foregut and Advanced GI Surgery and Director of the Bariatric and Metabolic Weight Loss Center at Stony Brook, a true comprehensive center for obesity management, including partners from Endocrinology, Obesity Medicine and Psychology. She is also director of the Advanced GI/MIS/Bariatric fellowship at Stony Brook. Her clinical practice includes bariatrics, general GI surgery, foregut and hernia.

Dr. Pryor's work has appeared in more than 100 publications, and she has co-edited four books. She has given more than 250 presentations worldwide, has received a number of research grants and holds patents for several surgical technologies. Her current research efforts focus on advancing laparoscopic bariatric and GI surgery techniques and outcomes, and on new technology in surgery. Her clinical care focuses on individualized treatment options of patients with gastroesophageal diseases, obesity and hernia. She offers a range of laparoscopic, endoscopic and traditional surgical approaches. She is actively engaged in several FDA trials and offers the latest available treatment options to her patients.

Dr. Pryor has been honored to be voted into several national leadership roles by her peers. She is the current President of the Society of American Gastrointestinal and Endoscopic Surgeons, which represents 7,000 surgeons specializing in gastrointestinal disease management. She is the First-Vice President of the Fellowship Council and slated to serve as president in 2020. She has also served on the Executive Council on the American Society of Metabolic and Bariatric Surgeons and has served as the Treasurer of three surgical societies. She currently has leadership positions in several other regional and national societies. Dr. Pryor's work through these societies helps to improve surgical delivery and education as well as to enhance patient access and care.

Richard D. Schulick
Professor & Chair of Surgery
University of Colorado, USA

Richard D. Schulick, MD, MBA, is Professor and Chair of the Department of Surgery at the University of Colorado School of Medicine. He also holds the Aragon/Gonzalez-Giusti Chair in surgery. Schulick came from the Johns Hopkins Medical Institutions where he was chief of the Surgical Oncology Division.

As the son of a U.S. diplomat, Schulick grew up around Washington, DC, and in Burma, Thailand, and India. He received his undergraduate degree in chemical engineering in 1985, medical school degree in 1989, and masters in business education in 2010, all from Johns Hopkins University, and completed a residency in General Surgery there in 1996. He completed fellowships in clinical pharmacology and immunology at the National Institutes of Health both in 1993, advanced gastrointestinal surgery at Johns Hopkins in 1997, and surgical oncology at Memorial Sloan-Kettering Cancer Center in 1999.

Schulick, who was on the Johns Hopkins faculty for 13 years, is a recognized leader in the fields of pancreatic, hepatic, and biliary surgery, as well as other areas in cancer surgery. His scientific interests are in the area of tumor immunology. He has also received recognition as a highly effective educator.

Schulick has served on the editorial boards of several journals in the field of surgery. He has authored or co-authored more than 280 peer reviewed scientific papers, invited manuscripts, and book chapters. He has obtained funding from both corporate and government agencies, including K23 and R01 funding, and has served on study sections of the National Institutes of Health. Schulick is a member of various organizations including the American Surgical Association, Society of Clinical Surgeons, American College of Surgeons, Society of Surgical Oncology, Americas Hepato-pancreato-biliary Association, Halsted Society, Western Surgical Association, Southern Surgical Association and James IV Association of Surgeons.

Lee L. Swanstrom
Chief Innovations Officer & Scientific Director
The Institute of Image-Guided Surgery of Strasbourg, France

Dr. Lee Swanstrom is the Chief Innovations Officer of the Institutes des Hôpitaux Universitaires of the University of Strasbourg, France. He sits on the Board of the American Board of Surgery and is Past President of the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) and of the Fellowship Council (FC). His clinical practice is primarily surgical endoscopy and foregut surgery.

Dr. Swanstrom received his MD degree from Creighton University following undergraduate work at the University of Paris (Sorbonne) and University of Colorado. He completed an internship and residency in general surgery in Portland and a fellowship in surgical endoscopy and GI surgery at the University of Western Ontario.

Dr. Swanstrom's clinical focus is on minimally invasive treatments of a variety of esophageal and gastrointestinal disorders, particularly utilizing laparoscopy and interventional flexible endoscopy. He is a well known researcher with over 250 scientific papers, 50 book chapters and is the editor of 2 major surgical textbooks and the journal Surgical Innovation. His research focus is in foregut physiology, human factors and technology assessment and new procedure development. This has resulted in 13 patents and a successful medical device startup company. He is and has been an investigator on numerous outcomes research studies for new procedures such as NOTES to determine their safety and efficacy for establishing new standards of care. He has served as a consultant to a large number of past and current medical device companies but his greatest pride has been the large numbers of fellows and residents who have been inspired to push the envelope in the field of GI surgery.

Kazuteru Monden
Director of Surgery
Fukuyama City Hospital, Japan

Kazuteru Monden is currently Director of Department of Surgery, Fukuyama City Hospital. He specializes in endoscopic surgery in the Hepatobiliary Pancreatic field. He graduated from JIKEI University School of Medicine in Tokyo in 2003 and received surgical training in Kanto Medical Center NTT EC and National Cancer Center Hospital East Chiba. He won the Best Video Award in the 14th Asia-Pacific Congress of Endoscopic and Laparoscopic Surgeon of Asia (ELSA 2019). He has several publications and presentation in the area of Laparoscopic liver resection.

Takashi Nonaka
Associate Professor
Nagasaki University Hospital, Japan

Takashi Nonaka is currently Associate Professor in the Department of Surgical Oncology at Nagasaki University Hospital. He graduated from Nagasaki University School of Medicine in 2001, after that received training and worked in the Department of Surgery, Ohmura municipal Hospital, Sasebo Chuo Hospital, Sasebo city general Hospital and Ureshino Medical center. He completed his Ph.D. degree at Nagasaki University in 2010. He became an assistant professor in 2010 and a hospital senior lecturer in 2018. Then, in November 2020, he became an associate professor.

In 2015, he received the Best Presentation Award from the Japanese Society for Cancer of the Colon & Rectum (JSCCR), and has been a JSES Endoscopic Surgical Skill Qualification judge. His special interests are minimal invasive surgery in colorectal disease. He had several publications and presentation in the area of Single Port Surgery, Robotic Surgery, trans-anal TME, trans-anal TPE and laparoscopic lateral lymph node dissection for rectal cancer.

Lau Yun Wong James
Chairman & Yao Ling Sun Professor of Surgery
Department of Surgery
The Chinese University of Hong Kong

Dr Lau graduated from the Medical School to the University of New South Wales in 1987. In the 1990s, Dr Lau was trained in upper gastrointestinal and therapeutic endoscopy. He received further training in vascular surgery in Edinburgh in 2000. Dr Lau currently leads the vascular surgical service at the Chinese University of Hong Kong. His current practice includes endoscopy with a focus on difficult ERCP, abdominal sarcoma surgery, open and endovascular surgery for vascular diseases.

Dr Lau has diverse research interests. He is internationally renowned for his clinical research in the management of patients with acute upper gastrointestinal bleeding and in therapeutic endoscopy specifically in biliary endoscopy and hemostatic techniques. In addition, he is interested in novel GI imaging techniques, epidemiology of ruptured abdominal aortic aneurysms.

Dr Lau became Professor to Surgery in 2008 and in addition received an endowed Professorship following a generous donation from late Mr. Yao Ling Sun. Dr. Lau received two National Awards and a Croucher Senior Medical Fellowship for his excellence in clinical research.

Mak Wing Chung Tony
Associate Professor, Department of Surgery
The Chinese University of Hong Kong

Dr. Tony Mak is a Specialist in General Surgery with more than 20 years of clinical experience. He was trained in the United Kingdom and pursued a career in General, Colorectal and Minimal Invasive Surgery before starting his career in Hong Kong in 2011. He is a skilled open and minimally invasive surgeon as well as a registered colorectal cancer screening endoscopist.

He was awarded a doctorate degree (M.D.) in 2008 for his work in Hereditary Non-polyposis Colorectal Cancer by the University of Manchester, United Kingdom.

He is an educator for both undergraduate students of CUHK and is a post-graduate colorectal surgical trainer for the College of Surgeons Hong Kong.

Administratively, he is the deputy director for the CUHK Jockey Club Minimally Invasive Surgical Skills Centre and is currently Council Member for both the Hong Kong Society for Coloproctology and Hong Kong Society of Robotic Surgery.

Teoh Yuen Bun Anthony
Associate Professor, Department of Surgery
The Chinese University of Hong Kong

Dr Anthony Y. B., TEOH is currently the Deputy Director of Endoscopy and Associate Professor in The Chinese University of Hong Kong. He graduated from the Chinese University of Hong Kong in 2001. After completing his surgical training, he has received overseas training in many international centres including the Kitasato University East Hospital and the Cancer Institute Hospital (Ariake) in Japan, the University of Washington, Cornell University and Stanford University in USA. He is a winner of multiple awards including 2019 Asian Pacific Digestive Week Emerging Leaders Lectureship, Carlos Pellegrini Traveling Fellow, American Society for Gastrointestinal Endoscopy endoscopic research awards, the GB Ong and Li Shield's Medal (best candidate in the fellowship examinations both locally and internationally).

Dr Teoh has served as a Visiting Professor to the Stanford Medical Center, Fujian University Medical Hospital, Consultant for Hepatopancreatobiliary Minimally Invasive Surgery Institute of Central South University.He is also a steering committee member for the Asian EUS group, member of upper GI committee of the World Endoscopy Organization, Secretary to the Hong Kong EUS society, council member of Hong Kong Hernia society, Hong Kong society of Robotic surgery and Hong Kong Society of Digestive Endoscopy. In addition, he is also an Associate Editor for Digestive Endoscopy and Techniques in Gastrointestinal Endoscopy. He is also in the editorial board for several internationally renowned journals including Clinical gastroenterology and hepatology, VideoGIE, Endoscopic ultrasound, Saudi journal of gastroenterology, World journal of Gastrointestinal endoscopy and World Journal of Gastroenterology. He has published over 123 journal papers and written 14 book chapters. He is currently a Consultant for Boston Scientific, Cook, Taewoong and Microtech Medical Corporations.

Weida Day
Associate Professor, Department of Medicine and Therapeutics
The Chinese University of Hong Kong

Dr. Weida Day is the Consultant of the Hong Kong Baptist Hospital and Honorary Clinical Associate Professor (Dept. Medicine and Therapeutics) in the Chinese University.

Dr. Day graduated from the University of Hong Kong in 1997. After the graduation, Dr. Day received his surgical training in Queen Mary Hospital until 2002 and joined Kwong Wah Hospital afterward. He obtained his specialist qualification as general surgery in 2005 and a master degree in Health and Hospital Management (University of Birmingham) in 2008. He was the founding member and secretary of the Public Surgeon Union in 2010. He was elected as the chairman of Younger Fellow Chapter in the College of Hong Kong Surgeon in 2011. In 2012, he decided to take up the challenge on working in private hospital, the Hong Kong Baptist Hospital, as a consultant. In 2016, he started the first case of transoral endoscopic thyroidectomy in the Hong Kong Baptist Hospital.

His special interests in general surgery are minimal invasive operations in colorectal surgery and thyroid surgery. He had several publications and presentation in the area of Endoscopic submucosal Dissection in colon, Single port colectomy and Transoral endoscopic thyroidectomy.

Ng Kwok Chai Kelvin
Professor, Department of Surgery
The Chinese University of Hong Kong

Prof. Ng graduated from the University of Hong Kong in 1995. He specializes in hepatobiliary and pancreatic surgery and liver transplantation. He was trained and worked in the Department of Surgery, The University of Hong Kong since 1996, and in The University of Hong Kong - Shenzhen Hospital in 2018. In 2019, Prof. Ng was appointed as Professor of Surgery in the Department of Surgery, The Chinese University of Hong Kong. Prof. Ng is a fellow of the Royal College of Surgeons of Edinburgh, the American College of Surgeons and the College of Surgeons of Hong Kong. He is also a member of several international professional organizations, including the International Society of Digestive Surgery and International Hepato-Pancreato Biliary Association. Internationally, he is the treasurer of International Society of Digestive Surgery Asia-Pacific (ISDS AP) and Asia-Pacific Digestive Week Federation (APDWF).

Prof. Ng's main research interests focus on the field of management of liver cancer and liver transplantation. His clinical researches in liver cancer range from surgical management for early cancer to local ablation therapy for advanced disease. He was awarded the postgraduate degree of Doctor of Philosophy on the study of local ablation therapy in animal models and the degree of Master of Surgery on the study of clinical applications of radiofrequency ablation for liver cancer. In 2002, Prof. Ng pioneered the application of radiofrequency ablation in the management of early liver cancer and he led a single-center randomized trial of hepatic resection versus radiofrequency ablation for early hepatocellular carcinoma, which was completed in 2007 with significant clinical results. The long-term follow-up results of this trial was published in British Journal of Surgery in 2018. Prof. Ng is one of the few transplant surgeons in Hong Kong, who can independently perform various types of liver transplant, including adult-to-adult living donor liver transplantation (LDLT) using right liver graft with middle hepatic vein or left liver graft using middle hepatic vein, adult-to-pediatric living donor liver transplantation, deceased donor liver transplantation (DDLT) and split-liver liver transplantation. His personal series of LDLT and DDLT is over 800 and 200, respectively. In 2009, he pioneered the issue of MELD exception policy for patient with T2 hepatocellular carcinoma in Hong Kong and he was involved in the first donor-exchange living donor liver transplantation in Hong Kong.

Prof. Ng is the author of over 95 peer-reviewed articles in international journals, including Annals of Surgery, British Journal of Surgery, Radiology and Hepatology. He is the editorial broad member of international journals, including The Surgeon and Medicine(R). He has delivered invited talks in various international conferences based on his renowned research works. Based on his academic achievements, he has received distinguished awards, including Gold Medal for Best Original Research, John Wong Young Surgeon's Award, Young Investigator Award, the G.B. Ong Travelling Fellowship, International Guest Scholarship and Carlos A. Pellegrini's Travelling Fellowship by American College of Surgeons.

Kaori Futaba
Assistant Professor, Department of Surgery
The Chinese University of Hong Kong

Dr Futaba is a General Surgeon with a specialist interest in colorectal surgery with more than 20 years of clinical experience. She graduated from Medical School at University of Birmingham in the United Kingdom. She completed her training in General, Colorectal and Minimally Invasive Surgery in the UK and was working as a Consultant Colorectal Surgeon at the University Hospital Birmingham, UK before joining the Department of Surgery as an Assistant Professor at the Chinese University of Hong Kong in 2016. She has specialist interest in minimally invasive colorectal surgery, pelvic floor and functional bowel disorders as well as in inflammatory bowel disease. She is committed to expanding the Functional Bowel Service in the Prince of Wales Hospital to help patients in Hong Kong suffering from functional bowel disorders.

She is passionate about Medical Education and is always looking for new ways to make learning fun for students. She has obtained a Master's degree in Medical Science in Clinical Education from the University of Nottingham in UK in 2009 with interest in simulation. She enjoys working on a variety of projects with students, trainees and colleagues to produce online learning materials for Medical students to stimulate their interest and encourage higher-order thinking to improve their understanding.

Her current research interest are in functional bowel disorders and inflammatory bowel disease. Whilst in UK, she was a founding member of a trainee-led research collaborative group allowing trainees to carry out meaningful clinical research together to make a difference. She continues to be involved in international collaborative research, including COVIDSurg with aim of finding ways of managing surgical patients as safely as possible during this Pandemic.

Au Kwok Wai Samuel
Associate Professor, Department of Mechanical and Automation Engineering
The Chinese University of Hong Kong

Samuel Au received the B.Eng. and M.Phil degrees in Mechanical and Automation Engineering from the Chinese University of Hong Kong, Hong Kong, China in 1997 and 1999, respectively. He completed his Ph.D. degree in Mechanical Engineering at MIT in 2007. During his PhD study, he invented (with Prof. Hugh Herr) the MIT Robotic Ankle-foot Prosthesis, which mimics the action of a biological ankle and, for the first time, provides transtibial amputees with a natural gait. This invention was named one of the Best Inventions of Year by TIME magazine in 2007 and was later commercialized by iWalk, Inc (now is called BionX Medical Technologes, Inc). Over one thousand of amputees have adopted to use this innovative prosthetic device in their daily life.

Dr. Au is an Associate Professor of the Department of Mechanical and Automation Engineering at The Chinese University of Hong Kong (CUHK) since Sept, 2016. Before joining CUHK, he was the manager of Systems Analysis of the New Product Development Department at Intuitive Surgical, Inc. At Intuitive Surgical, he co-invented and led the product development (SW and Control Area) of the FDA approved daVinci Si Single-Site surgical platform (2012), Single-Site Wristed Needle Driver (2014), and daVinci Xi Single-Site surgical platform (2016). daVinci SingleSite platform was the first FDA approved robotic platform to support single incision surgery. Since the official launch at Dec 2012, over 110K patients have received the single incision surgery through this platform and more than 500 clinical centers/hospitals around the globe have been using this platform for research studies as well as their clinical practice.

Dr. Au is the author and co-author of over 12 peer-reviewed manuscripts and conference journals, and has more than 20 patents pending. His inventions/works featured in numerous magazines such as New York Times and Technology Review. He has won numerous awards including the first prize in the American Society of Mechanical Engineers (ASME) Student Mechanism Design Competition in 2007, Intuitive Surgical (ISI) Problem Solving Award in 2010, and Intuitive Surgical (ISI) Inventor Award in 2011.

Kai Pun Wong
Private Practice

Dr Wong Kai Pun, obtained the medical degree in the University of Hong Kong in 2005 and became Fellow of the Hong Kong Academy of Medicine (General Surgery) in 2012. He has completed the Postfellowship Training in Endocrine Surgery and joined Department of Surgery, The University of Hong Kong as Clinical Assistant Professor in 2015. He started his private practise as a Consultant Surgeon in August 2019.

Dr. Wong has been an active academic endocrine surgeon who performed more than 2,100 thyroidectomies, 350 parathyroidectomies and 150 adrenalectomies. His clinical interests are Graves' disease, endocrine oncology and minimally invasive treatment for thyroid disorder. Since 2011, 57 articles have been accepted and published, while Dr. Wong is the principle author in 19 of them. Majority were endocrine disease related. He has presented 51 conference papers in local and international meetings.

Throughout his medical career, he has received numbers of awards, namely Travel Awards by International Association of Endocrine Surgeons, Resident / Fellow Research Award, Clinical Research, by the American Association of Endocrine Surgeons (AAES), GB Ong Travelling Grant, MAS Travelling Scholarship. And he recently have awarded the Health and Medical Research Fund (HMRF) 2018 and General Research Fund (GRF) 2018 from the Research Grants Council (RGC).

Other than academic research, he has been actively involved in teaching and education of medical personnel. He pioneered the application of surgical ultrasound among medical undergraduates. He has been an invited speaker and delivered more than 20 lectures in scientific congresses for specialists.

Herbert H. Loong
Clinical Assistant Professor, Department of Clinical Oncology
Deputy Medical Director, Phase 1 Clinical Trials Centre
The Chinese University of Hong Kong

College of Physicians (United Kingdom) in 2006 and a Fellow of the Hong Kong College of Physicians and Hong Kong Academy of Medicine in 2010. He has completed a Fellowship in Drug Development at Princess Margaret Cancer Centre in Toronto, Canada with a special focus on Experimental Therapeutics. His clinical and research interests also include Sarcoma Medical Oncology, Thoracic Oncology and Neuro-oncology.

Through the American Society of Clinical Oncology (ASCO) and Health Volunteers Overseas, Dr. Loong regularly volunteers in the teaching of medical students and resident trainees of developing nations. His mission in March 2015 brought him to Hue, Vietnam. He also serves as a recurring faculty member on the ASCO Multidisciplinary Cancer Management Course (MCMC), through which he has had the opportunity to share his interests with participants from the Philippines (2014) and Azerbaijan (2018).

Dr. Loong currently serves as a committee member on the Pharmacy and Poisons Board of Hong Kong which oversees the registration and regulation of pharmaceutical products and clinical trials in the territory. He also serves on the ASCO International Affairs Committee and the International Association for the Study of Lung Cancer (IASLC) Communications Committee.

Dr. Loong is a recipient of the European Cancer Congress Fellowship Grant (2013), the ASCO Annual Meeting Merit Award (2014), the Hong Kong College of Physicians Young Investigators’ Award (2014), and the Hong Kong Society of Neuro-Oncology Travelling Sponsorship Grant (2015 & 2016). Nominated by patients and their caregivers, Dr. Loong led the Lung Cancer Team at CUHK to be bestowed the IASLC Foundation Cancer Care Team Award in recognition for providing the best thoracic oncology care in "Asia & Rest of the World" in 2018.

Francis PT Mok
Clinical Professor (honorary)
Faculty of Medicine
The Chinese University of Hong Kong

Dr. Mok graduated MBBS from The University of Hong Kong (HKU) in 1980. After a year of internship in surgery and in medicine in Queen Mary Hospital (QMH), and a year working as Medical Officer in the Accident and Emergency Department in Queen Elizabeth Hospital, he joined the University Surgical Unit (USU) in 1982. Having undergone training in different specialties of surgery, he obtained FRCSEd in 1985, FCSHK and FRACS in 1990, FHKAM(Surg) in 1993, and Specialist in General Surgery Registration in Hong Kong in 1998. He pursued sub-specialty training in hepatobiliary-pancreatic surgery (HBP) & upper gastrointestinal (UGI) surgery in Hong Kong, working with Professor S T Fan and Professor Frank Branicki, and in Glasgow Royal Infirmary in 1987, under the tutelage of Professor David Carter & Professor James Garden. He also received training in flexible endoscopy in Tokyo Women’s Hospital in 1990. While in QMH, he was involved heavily in research, in conducting randomized controlled trial in the use of ERCP in acute cholangitis and in acute pancreatitis, leading to publications in leading medical journal-New England Journal of Medicine. He was promoted Consultant Surgeon of USU, Kwong Wah Hospital, in 1991, and was appointed Chief of Service (Surgery) & Combined Endoscopy Unit, Caritas Medical Centre (CMC), in 1995 till his retirement in 2015 at the age of 60. Later in the year, he was rehired as full-time Consultant Surgeon in Tuen Mun and Pok Oi Hospital of the New Territories West Cluster (NTWC) of Hospital Authority (HA). He helps with teaching, training, quality improvement, major HBP surgery, and to kick-start emergency surgical service in Pok Oi Hospital. After finishing a 2 year contract with NTWC, he returned to CMC in December 2017, and work as part-time Consultant Surgeon, working 4 days a week, doing teaching and training of HBP and UGI surgeons. He is now also appointed as Honorary Consultant to the Department of Surgery in Tuen Mun Hospital.

Daisy MY Kan
Consultant Surgeon, Department of Surgery
Kwong Wah Hospital, Hospital Authority

Dr. Daisy Kan is the Consultant Surgeon of the Department of Surgery, Kwong Wah Hospital, subspecializing in endocrine surgery. She joined the Department of Surgery of Surgery, Kwong Wah Hospital in 2000 and received general surgical training. After obtaining fellowship in general surgery, she received training in endocrine surgery in New York and Seoul, with exposure to various surgical approaches to thyroidectomy.

She is the Council member, Hong Kong Thyroid Society since 2011, the Vice Chairlady of the Hong Kong Thyroid Society 2016, the council member and the Secretary of HKAES.

Kit-Fai Lee
Consultant Surgeon, Department of Surgery
Prince of Wales Hospital, Hospital Authority

Dr. Kit-Fai Lee graduated from the Medical School of the University of Hong Kong in 1988. Since then he persued his training in surgery in Kwong Wah Hospital. He had six months training in hepatobiliary surgery in the Cleveland Clinic Foundation in the United States in the second half of 1996. He subsequently joined the Division of Hepato-biliary and Pancreatic Surgery in the Department of Surgery, Princes of Wales of Hospital in 2002. His current position is Consultant Surgeon and Clinical Associate Professor (honorary) in the Department of Surgery, Prince of Wales Hospital, the Chinese University of Hong Kong. He is also the Vice President of the Hong Kong Society of Hepatobiliary and Pancreatic Surgery. Dr. Lee is interested in a wide variety of hepatobiliary diseases, and on surgical technique in liver resection, pancreatic resection, laparoscopic and robotic surgery. He is involved in a number of studies on technique in liver resection, local ablation treatment and transarterial therapy for liver cancer. Dr. Lee has more than 100 peer reviewed publications on topics related to hepatobiliary diseases and general surgery. He is also a reviewer for several local and international surgical journals.

Shirley YW Liu
Consultant, Department of Surgery
Prince of Wales Hospital, Hospital Authority

Dr Shirley Liu is the Head of Endocrine Surgery Division of Prince of Wales Hospital & Alice Ho Miu Ling Nethersole Hospital in Hong Kong. She is also a Clinical Assistant Professor (Honorary) at the Department of Surgery of the Chinese University of Hong Kong.

Shirley graduated from the Chinese University of Hong Kong in 2003 with Distinction in Surgery. She completed her general surgery residency in Prince of Wales Hospital and obtained fellowships from the Royal College of Surgeons of Edinburgh and the College of Surgeons of Hong Kong in 2010. She started her practice as an endocrine and bariatric surgeon since 2010. She is an active researcher and her academic contributions have been recognized by over 20 international awards, including the Fujimoto Prize (First Prize) from the Asian Association of Endocrine Surgeons in 2014, the International Association of Endocrine Surgeons (IAES) Best Clinical Paper Prize in 2015, and the IAES Dr John Farndon Award in 2017.

With strong enthusiasm in the local development of endocrine surgery, Shirley took the initiative in establishing the Hong Kong Association of Endocrine Surgeons (HKAES) in April 2019 and serves as the founding Vice President of the Association. She is also currently working as the President (Hong Kong, China Region) of the Chinese Young Federation for the Surgery of Obesity & Metabolic Disorders, the Vice President of the Younger Fellow Chapter of the College of Surgeons of Hong Kong, and the council members of the Hong Kong Society of Minimal Access Surgery (HKSMAS), the Hong Kong Thyroid Society (HKTS), the Hong Kong Society of Metabolic and Bariatric Surgery (HKSMBS) and the Hong Kong Society of Parenteral & Enteral Nutrition (HKSPEN).

Philip WY Chiu
Professor, Department of Surgery
The Chinese University of Hong Kong

Professor Philip Chiu is currently Professor and Honorary Consultant of Division of Upper GI and Metabolic Surgery, Department of Surgery; Prince of Wales Hospital; Director of CUHK Jockey Club Minimal Invasive Surgical Skills Center; Director of CUHK Chow Yuk Ho Technology Center for Innovative Medicine and Assistant Dean (External Affairs), Faculty of Medicine, Chinese University of Hong Kong. He also serves as Director of Endoscopy of Prince of Wales Hospital and Cluster Director of Endoscopy, New Territories East Cluster, Hospital Authority.

Prof. Chiu is first to perform endoscopic submucosal dissection (ESD) for treatment of early GI cancers in Hong Kong in 2004. In 2010, he performed the first Per-oral Endoscopic Myotomy (P.O.E.M.) in Hong Kong. His research interests include upper gastrointestinal bleeding, esophageal cancer and minimally invasive and robotic esophagectomy, novel endoscopic technologies for diagnosis of early GI cancers, ESD and novel endoscopic procedures as well as Natural Orifices Transluminal Endoscopic Surgery (NOTES). He has published more than 260 peer reviewed manuscripts and 6 book chapters. He received numerous prestigious awards including State Scientific Technology and Progress Award from People’s Republic of China in 2007, 2nd class award in Technological Advancement, Ministry of Education of the People’s Republic of China in 2011. He served as Yeoh Ghim Seng Visiting Professor at Department of Surgery, National University of Singapore from 2014-2017. His research on POEM was awarded best of DDW 2011 and first prize of ASGE world cup of endoscopy 2012. He was selected as Asia Pacific Digestive Week JGHF Emerging Leader Lectureship in 2016 and Global Outstanding Chinese Youth 2016. He is currently co-editor of Endoscopy and subject editor for Surgical Endoscopy.

Zheng Li
Assistant Professor, Department of Surgery
The Chinese University of Hong Kong

Zheng LI obtained his PhD degree in CUHK, Master degree and Bachelor degree in Beihang University. He is currently an Assistant Professor in department of Surgery and an associated member of Chow Yuk Ho Technology Centre for Innovative Medicine, department of biomedical engineering and T Stone Robotics Institute of the Chinese University of Hong Kong. He is also an adjunct associate professor of Monash University, Australia. Previously, he worked as a research assistant professor in the institute of digestive disease and as a research fellow in National University of Singapore. He is a senior member of IEEE (Institute of Electrical and Electronics Engineers), member of ASME (The American Society of Mechanical Engineers), and member of RAS (Robotics and Automation Engineering). Zheng served as the editor of BioRob 2020 and associate editor of RA-L (Robotics and Automation Letters), associate editor of ICRA (International Conference on Robotics and Automation), IROS (International Conference on Intelligent Robots and Systems), etc. He served as the reviewer of over 30 peer reviewed journals/conferences.

Zheng's current research mainly focuses on the topic of innovative medical robots/devices, including intelligent flexible surgical robot for minimally invasive surgery, soft medical robots for gastrointestinal tract inspection, soft medical robots for rehabilitation, magnetic anchored and guided system for VATS, semi-autonomous robots for stereotactic brain biopsy, etc. His research is well supported by the Hong Kong Research Grant Council and Innovative Technology Fund, etc. His research work yield over 10 patents/copyright, 1 edited book and was published in over 100 peer reviewed journals/conferences/book chapters, including both leading engineering journals e.g. IJRR, SORO, TMech, TNNLS, TIE, Engineering, Frontiers in bioengineering and biotechnology, MMT, RA-L, etc. and top clinical journals, e.g., Surgical Endoscopy, Endoscopy. His work was recognized by receiving the conference paper award of CCECE 2015, best paper finalist of Robio 2012, CCECE 2015, best poster finalist of ICRA 2017, Silver of 2019 International Exhibition of Inventions Geneva, Gold of 2019 Emedic global, Silver and Technical Challenge Award of 2018 Emedic Global, Champion of 2017 PCKKSCA, Gold of 2017 JEC Outstanding engineering project award, Gold of 2016 HKEIA Innovation & Technology Project Competition Award, Most Innovative Design Award of 2016 Emedic Global, etc.

Enders KW Ng
Professor, Department of Surgery
The Chinese University of Hong Kong

Professor Enders Ng obtained his medical degree from the Chinese University of Hong Kong in 1989. He embarked on both basic and clinical research shortly after finishing his surgical training in the mid-1990s. He received the higher degree of Doctor of Medicine (CUHK) in 1999 for his work on investigating the relationship between Helicobacter pylori and peptic ulcer diseases. His other research foci include interventional endoscopy and surgical oncology for oesophagogastric malignancies. Over the years, he was awarded by different authorities and societies for research achievement, including Young Scientist Research Prize in the 4th United European Gastroenterology Meeting (1994) and Young Scientist Award in the 11th International Workshop on Gastroduodenal Pathology and Helicobacter pylori in Hungary (1998). His work on peptic ulcer complications has also led him to the winning of Second-Class Award of the 2007 State Scientific and Technological Progress Award of China. Up to now, he has published over 200 articles in various international peer-reviewed journals and more than 10 book chapters in Surgery and Endoscopy.

Professor Ng's interest of research has expanded to metabolic and bariatric surgery, as well as surgical nutrition in the last decade. He was the Founding President of the Hong Kong Society of Upper Gastrointestinal Surgeons from 2006 to 2010. He is also the President of Hong Kong Society of Parenteral and Enteral Nutrition since 2007. He has been repeatedly elected as Councillor of the College of Surgeons of Hong Kong since 2007, and was the Vice-President (Internal Affairs) from 2013 to 2019. He is now the Associate Dean (Alumni Affairs) to the Faculty of Medicine, The Chinese University of Hong Kong. His current post is the Chief of Service in Surgery at Prince of Wales Hospital and also the Cluster Surgery Director of the New Territories East Cluster of the Hospital Authority. He is a keen teacher and trainer. His passion and enthusiasm in medical education has led him to become the curriculum coordinator for the final year curriculum of the medical school since 2015. His fondest hobbies are Chinese Calligraphy, hiking and Endurance Running.

Simon SM Ng
Professor, Department of Surgery
The Chinese University of Hong Kong

Prof Simon Ng graduated from the medical school of The Chinese University of Hong Kong (CUHK) in 1995 with 7 distinctions and was awarded the honour degree and double Gold Medals. He passed the Joint Specialty Fellowship Examination in General Surgery in 2002 with highest marks and won the Li-Shields Medal. In 2013, Prof Ng received his Medical Doctoral Degree with Commendation from CUHK for his research thesis on the long-term outcomes of laparoscopic surgery for rectal cancer.

Prof Ng is currently Associate Dean (Student Affairs) of the Faculty of Medicine, and Professor of the Division of Colorectal Surgery, CUHK. He is also the Director of the Global Physician-Leadership Stream of the MBChB Programme, CUHK. He is the President of the Hong Kong Society for Coloproctology, a Council Member of the Hong Kong IBD Society and the Hong Kong Society of Robotic Surgery, an Honorary Member of the Korean Association of Robotic Surgeons, a Board Member of the Asia Pacific Endo-Lap Surgery Group, a Governing Council Member of the Asia-Pacific Federation of Coloproctology, a Fellow of the American Society of Colon and Rectal Surgeons (ASCRS), and the International Chair of the Global Reach Committee of the European Society of Coloproctology (ESCP).

Prof Ng's main clinical and research interests are minimally invasive/robotic surgery and advanced endoscopic therapy for colorectal diseases, multimodality treatment for colorectal cancer, colorectal cancer screening, biomarkers for colorectal cancer, and integrative medicine. His research work in colorectal surgery has earned him a number of international and national awards, including the Northern California Society of Colon and Rectal Surgeons Award of the ASCRS (2008), the International Guest Scholarship of the American College of Surgeons (2010), the GB Ong Traveling Fellowship (2011), the British Journal of Surgery Prize of the ESCP (2011 and 2014), the Royal College of Surgeons of Edinburgh China Medal (2014 and 2016), the Ministry of Education Higher Education Outstanding Scientific Research Output Award – First-class Award in Natural Sciences (2014), the State Natural Science Award – Second-class Award (2016), and the Outstanding Fellowship of the Faculty of Medicine, CUHK (2019).

On the pedagogical side, Prof Ng had received eleven Teacher of the Year Awards of the Faculty of Medicine from 2005 to 2018, and the Master Teacher Award in 2011. In recognition of his outstanding performance in the surgical profession and his contribution to the community, Prof Ng was selected as one of the awardees of the Ten Outstanding Young Persons of Hong Kong in 2010.

Vivien Wong
Private Practice

Dr. Vivien Wong graduated from the Chinese University of Hong Kong, received training and worked in the Department of Surgery, Prince of Wales Hospital, Hong Kong. She has special interest in functional foregut disorders and received overseas training in high-resolution manometry and other surgical and endoscopic treatments in the Institute of Image-Guided Surgery in Strasbourg, France. During her years working in the Division of Upper GI & Metabolic Surgery as a specialist, she focused on care for functional foregut disorders, including running the surgical motility diagnostic laboratory, performing surgical and endoscopic treatments such as per-oral endoscopic myotomy (POEM) proctored by Professor Philip Chiu, being involved in studies on achalasia and reflux treatments, and running workshop on high-resolution manometry and other functional diagnostic tests.

Olympus Hong Kong

At Olympus we aim to deliver total medical solution with complete customer satisfaction. Our medical products cover gastrointestinal endoscopes, endotherapy devices, endoscopic ultrasound systems, surgical endoscopes and instruments and integrated operating theatre. As a leading endoscope company, Olympus is promoting the advancement of minimally invasive diagnosis and treatment as well as product development to offer our customers improved safety, security, quality and productivity.

Website: olympusmedical.com.hk

Ms Fayzi Lee
+852 2170 5678
+852 2170 5679
0900 - 1800 Monday - Friday
L26, Tower 1, Kowloon Commerce Centre, 51 Kwai Cheong Road, Kwai Chung, N.T., Hong Kong

Medtronic Hong Kong

At Medtronic, we believe in the power of medical technology to improve lives. Seven decades ago, our co-founder invented the battery-powered pacemaker. Today, we are among the largest medical device companies in the world. With operations in 150 countries, our products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Our therapies help 72 million people a year and support our Mission to alleviate pain, restore health, and extend life.

Our people make it possible. We value diverse perspectives and encourage our 90,000+ employees to be themselves. We hold each other accountable, act with integrity, and make quality our highest priority.

We are privileged to be part of the communities where we live and work. We are committed to giving back and reducing our impact on the environment.

Let's take healthcare Further, Together.

Mr. Angus Lo   (Product Manager)
+852 2919 1300
+852 2838 0749

Ms. Jo Ng   (Asso Product Manager)
+852 2919 1300
+852 2838 0749

Suite 1104-11, 11/F, Tower 1, The Gateway, 25 Canton Road, Tsimshatsui, Kowloon, Hong Kong

Website: www.medtronic.com

KARL STORZ Endoscopy China Ltd

Since its beginnings in 1945, the KARL STORZ family company has grown into a global manufacturer and distributor of endoscopes, medical instruments, and devices. We are no giant on an international scale but a leader in the things that matter: creativity, flexibility, and expertise.

Our range of endoscopic instruments for human medicine, veterinary medicine, and industrial endoscopy now includes more than 15,000 products. The most recent KARL STORZ developments are in digital documentation systems and comprehensive operating room concepts. As a system supplier, the company combines its expertise in endoscopy with software solutions to achieve integration in the operating room and to support clinical process and resource management.

Peter Jin   (Marketing Manager, KARL STORZ Endoscopy China Ltd)
+852 6469 1936
+852 3180 4289
+852 2865 4114

Website: www.karlstorz.com

Download IMAGE1 STM RubinaTM Brochure: Rubina Brochure.pdf

Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.
Every day, our more than 130,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.

Joan Lai   (Senior Product Manager)
+852 6275 6266

Grace Wong   (Product Manager)
+852 9570 3855

Website: www.jnj.com Virtual Booth

Astra Zeneca

We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Our purpose and values help explain why we exist, what we hope to accomplish, the behaviours we value, how we will achieve our goals, and the promise of our brand to our stakeholders.

Mr John Leung
+852 8209 9568

Ms Connie Chan
+852 6903 8395

Website: www.astrazeneca.com

Intuitive Surgical-Fosun (Hongkong) Co., Limited

Intuitive Surgical, Inc. and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. – Intuitive Surgical-Fosun (Hongkong) Co., Limited announced on 29 September 2016 a joint venture to develop, manufacture and sell innovative, robotic-assisted medical systems. Intuitive Surgical is the pioneer and global leader in robotic-assisted minimally invasive surgery. The company designs, manufactures and sells da Vinci ® surgical robots. Shanghai Fosun Pharmaceutical is a leading healthcare group strategically comprising the complete value chain. Intuitive Surgical-Fosun will initially produce a less invasive and more flexible robotic catheter platform targeting early diagnosis and treatment of lung cancer. The company is committed to benefiting patients all over the world and helping improve healthcare over the long term, in the spirit of "Made in China, joint research & development, global sales".

Ms Arcux Leung   (Sales Supervisor)
+852 3844 6500
+852 3619 4190
3301B-03, AIA Tower, 183 Electric Road, North Point, Hong Kong

Website: www.investhk.gov.hk

Boston Scientific

We're dedicated to collaborating with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, increase efficiencies and—most importantly—help more people in more places around the world live longer, healthier lives.

Mr. Desmond Wan
+852 2960 7100
+852 2563 5276
0900 - 1800 Monday - Friday
Suite 2601-02 & 09-11, 26/F, Dorset House, Taikoo Place, 979 King’s Road, Quarry Bay, Hong Kong

Website: www.bostonscientific.com/en-US


Good food, good life – that is what we stand for. Everything you need to know about Nestlé is here: brands, key figures, milestones.

Eve Wong   (Field Operation Manager)
+852 6282 1494
+852 2504 2621

Website: www.nestle.com.hk